Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis

Authors
Fam, AG Perez-Ordonez, B Imrie, K
Citation
Ag. Fam et al., Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis, J RHEUMATOL, 27(6), 2000, pp. 1546-1549
Citations number
16
Categorie Soggetti
Rheumatology,"da verificare
Journal title
JOURNAL OF RHEUMATOLOGY
ISSN journal
0315162X → ACNP
Volume
27
Issue
6
Year of publication
2000
Pages
1546 - 1549
Database
ISI
SICI code
0315-162X(200006)27:6<1546:PCBCLD>2.0.ZU;2-I
Abstract
A patient with rheumatoid arthritis developed a reversible, primary cutaneo us, large B cell lymphoma during prolonged methotrexate (MTX) treatment. Re gression of the skin lesions after discontinuation of the drug suggested a close relationship to MTX. Increased clinical awareness, discontinuation of MTX, and close observation are important in the initial management of this rare lymphoproliferative disorder.